Proteon Pharmaceuticals India - a subsidiary of Proteon Pharmaceuticals SA Poland, will focus on the development of bacteriophages as a sustainable alternative to antibiotics in the poultry industry.
It is engaged in the development of precision biology for microbiome protection to improve animal and human health and eliminating the unnecessary use of antibiotics.
Elaborating on Proteon Pharmaceuticals product development strategy, Dr Ramdas Kambale – Director- (Sales - Asia Pacific) said, “Antibiotics usage in chicken is a big concern for food safety and it is really important to take this forward to stop or minimise the usage of antibiotics and look seriously the bacteriophages as its clear-cut alternative.”
He also added that the growing population needs to be fed with a proper protein diet which can be achieved by chicken meat being easily and safely available for sustainable consumption.
Proteon Pharmaceuticals India had recently introduced, BAFASAL+G, a feed additive that prevents and eliminates salmonella on the poultry farm while keeping the microflora in the gut intact.
Proteon uses precision biology for microbiome protection to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.